This contract expires in 266 days (Mar 31, 2027).

Browse related active opportunities

FIRM FIXED PRICENO SET ASIDE USED.

HEXAMER THERAPEUTICS INC. - RESEARCH AND DEVELOPMENT SERVICES BA230121 TITLED SELF ASSEMBLING VACCINE PLATFORM

PIID: HT942523C0078Solicitation ID: HT942523SBAA1
Signed Date: Nov 25, 2025Effective Date: Sep 29, 2023End Date: Closes in 266 days
Award $
$3.9M
Vendor
HEXAMER THERAPEUTICS INC.
NAICS
541714
Signed Date
Nov 25, 2025

Key Details

Dollars Obligated
$3.9M
Base & All Options
Awarding Agency
Department of Defense
Awarding Sub-Agency
Defense Health Agency
Product Service Code
AN11 - HEALTH R&D SERVICES; HEALTH CARE SERVICES; BASIC RESEARCH
Extent Competed
FULL AND OPEN COMPETITION
Number of Offers
1
Place of Performance
PULLMAN, WA, 991635601, CD-WA-05

Description

RESEARCH AND DEVELOPMENT SERVICES BA230121 TITLED SELF ASSEMBLING VACCINE PLATFORM

Context & Analysis

On Nov 25, 2025, Department of Defense obligated $3,928,061.02 to HEXAMER THERAPEUTICS INC. for research and development services ba230121 titled self assembling vaccine platform. The award is classified under NAICS 541714 — RESEARCH AND DEVELOPMENT IN BIOTECHNOLOGY (EXCEPT NANOBIOTECHNOLOGY) and issued as a firm fixed price contract. Competition extent: full and open competition with 1 offer received. The procurement used a NO SET ASIDE USED. set-aside. Performance is located in PULLMAN, WA. The contract is scheduled through Mar 31, 2027 — approximately 9 months remaining.

Contractor Information

UEI: MK8HSFMVB647
CAGE Code: 9CUB9
Location: PULLMAN, WA
View Full Record on USASpending.gov

Stay Updated

Get notified about new opportunities matching your interests.

Related